Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_5551F9C73188
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Périodique
Haematologica
ISSN
1592-8721 (Electronic)
ISSN-L
0390-6078
Statut éditorial
Publié
Date de publication
01/01/2023
Peer-reviewed
Oui
Volume
108
Numéro
1
Pages
234-239
Langue
anglais
Notes
Publication types: Clinical Trial ; Letter
Publication Status: epublish
Publication Status: epublish
Résumé
Not available.
Mots-clé
Adult, Humans, Clinical Trials as Topic, Dexamethasone, Etoposide, Leukemia, Myeloid, Acute, Lymphohistiocytosis, Hemophagocytic/diagnosis, Lymphohistiocytosis, Hemophagocytic/drug therapy, Lymphohistiocytosis, Hemophagocytic/etiology, Pilot Projects
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/09/2022 9:19
Dernière modification de la notice
08/07/2023 5:49
Données d'usage
